AMDA is challenging industry clinicians and operators to join a push to reduce polypharmacy. Prescribing data will be collected and overall trends analyzed and shared with participants.
NIH updates monoclonal antibody COVID treatment protocols … Surveyed community pharmacists say vaccine supply is bigger problem than patient reluctance … B.1.1.7 variant more transmissible but does not increase disease severity, two new studies suggest … The U.S. nears universal COVID vaccine eligibility for adults … CDC studies breakthrough COVID infections: The vaccines are protective, but not by 100% … Michigan warned to shut down again due to COVID surge
Clinicians may want to intentionally emphasize side effects when prescribing new medications to older patients, a new study suggests.
Nursing home and assisted living operators should talk with their existing pharmacy provider about their capability to participate in the federal government’s new COVID-19 vaccine delivery program, advocates say.
Long-term care facilities nationwide can voluntarily opt in to a free pharmacy partnership program that will provide and administer future COVID-19 vaccines on site, federal officials announced Friday.
Only 29% of seniors who take five or more prescription drugs have had a comprehensive medication review to avert potential interactions, according to new national findings.
Qualified pharmacists serving long-term care facilities will now be able to administer COVID-19 vaccines to residents and staff members once the serum is ready, under new guidance announced Wednesday by federal health officials.
Pharmacists are advocating to insert a policy in the upcoming coronavirus relief bill that would give them Medicare Part B provider status for conducting COVID-19 testing and vaccinations.
Suspected coronavirus leads to no-visitor policies at Nebraska senior living communities … Low blood pressure linked to higher mortality in elders, finds UK study … Pharmacists quietly panicking over looming respiratory drug shortage … Social service workers have positive impact on residents’ behavior, study finds …FDA approves first US OTC combination of ibuprofen and acetaminophen
A powerful congressman has asked long-term care pharmacists to help monitor and reduce antipsychotic use in nursing homes.
